by James Edward Katz, M.D. | Jun 2, 2014 | Age Management, Disease, Health Supplements, Patient Care, Preventative Medicine
Last year, the American Heart Association and American College of Cardiology released new guidelines for the treatment of an increase in the risk of heart disease with statin lowering drugs like Lipitor. The previous guidelines (Adult Treatment Panel Guidelines (ATP...
by James Edward Katz, M.D. | Apr 24, 2014 | Depression, Health Supplements, Hormone Supplementation Therapy, Medicare, Medications, Preventative Medicine
Headline: Testosterone Doubles the Incidence of Heart Attack (2014) Reality: Testosterone Group had 0.7% more Heart Attacks A paper by Finkle et. al. (Increased Risk of Non-Fatal Myocardial Infarction [Heart Attack] Following Testosterone Therapy Prescription in Men)...
by James Edward Katz, M.D. | Apr 5, 2014 | Alzheimer's, Health Supplements, Medications, Preventative Medicine
For ten years, Merck has been pursuing one of the Holy Grails in pharmaceuticals. Aspirin is one of the most recommended drugs in the world. Merck has been developing laropiprant to replace aspirin. But laropiprant was a long shot as it has a paradoxical dose-...
by James Edward Katz, M.D. | Jan 20, 2014 | Age Management, Aging, Exercise, Fitness, Preventative Medicine
Between diving for basketballs, rock climbing, and riding dirtbikes, I have had some hard landings, but none recently until last June. I was riding my bicycle, when a woman, with her infant in a papoose, decided to stop directly in front of me in a crowded crosswalk...
by James Edward Katz, M.D. | Dec 27, 2013 | Insurance, Medicaid, Medicare, Obamacare, Patient Care, Policy, Preventative Medicine
“If you think health care is expensive now, wait until you see what it costs when it’s free.”
- P.J. O’Rourke Regardless of one’s political persuasion, no one hopes for a future health system that creates worse patient outcomes at higher cost. However,...
by James Edward Katz, M.D. | Nov 9, 2013 | Age Management, Cancer, Disease, Health Supplements, Hormone Supplementation Therapy, Preventative Medicine
The WHI (now over a decade old) remains the largest randomly controlled trial of women’s hormonal medicines. The original publication of WHI identified increased risks of breast cancer, stroke, and cardiovascular disease associated with hormone therapy. These findings...
by James Edward Katz, M.D. | Nov 9, 2013 | Age Management, Aging, Cancer, Dementia, Disease, Medications, Preventative Medicine
The M. D. Anderson Hospital reported that Celebrex, an arthritis medication, reduced precancerous markers in smokers. Sloan-Kettering Hospital in New York confirmed similar results. Neither study was structured to see if Celebrex reduced lung tumors (that takes 10+...
